Utah Medical Products (NASDAQ:UTMD) Shares Cross Above 200-Day Moving Average – What’s Next?

Utah Medical Products, Inc. (NASDAQ:UTMD)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $57.90 and traded as high as $58.15. Utah Medical Products shares last traded at $57.21, with a volume of 9,381 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Utah Medical Products in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Utah Medical Products Price Performance

The company has a market cap of $183.42 million, a price-to-earnings ratio of 16.16 and a beta of 0.33. The business’s 50-day simple moving average is $61.08 and its 200-day simple moving average is $57.90.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Thursday, October 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a net margin of 30.08% and a return on equity of 9.90%. The business had revenue of $9.81 million for the quarter.

Utah Medical Products Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, January 5th. Shareholders of record on Tuesday, December 16th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Tuesday, December 16th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.31. This represents a $1.24 annualized dividend and a yield of 2.2%. Utah Medical Products’s dividend payout ratio (DPR) is 35.03%.

Institutional Trading of Utah Medical Products

Several institutional investors and hedge funds have recently made changes to their positions in UTMD. Brandes Investment Partners LP boosted its stake in shares of Utah Medical Products by 12.0% during the second quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier’s stock valued at $15,444,000 after acquiring an additional 29,073 shares during the last quarter. Hotchkis & Wiley Capital Management LLC lifted its holdings in Utah Medical Products by 35.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock valued at $5,696,000 after purchasing an additional 26,460 shares in the last quarter. Everett Harris & Co. CA boosted its stake in shares of Utah Medical Products by 327.7% during the 1st quarter. Everett Harris & Co. CA now owns 17,116 shares of the medical instruments supplier’s stock worth $959,000 after purchasing an additional 13,114 shares during the last quarter. Huber Capital Management LLC grew its holdings in shares of Utah Medical Products by 38.9% during the first quarter. Huber Capital Management LLC now owns 39,819 shares of the medical instruments supplier’s stock worth $2,231,000 after buying an additional 11,149 shares in the last quarter. Finally, Quantinno Capital Management LP purchased a new stake in shares of Utah Medical Products during the second quarter worth about $608,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.